Development of sesquiterpenes from Alpinia oxyphylla as novel skin permeation enhancers.
To improve the drug permeation into and/or across the skin, essential oils extracted from Alpinia oxyphylla (AO) were evaluated using in vitro and in vivo permeation techniques with Wistar rats as the animal model. Hydrocarbons and oxygenated sesquiterpenes were the major components in the lower-polarity fraction (AO-1) and higher-polarity fraction (AO-2), respectively. Permeation of indomethacin was significantly enhanced after treatment with AO-1 and AO-2 in the in vitro and in vivo studies. AO-2 generally showed a higher ability to promote drug permeation compared to AO-1. The increment of skin/vehicle partitioning may be the predominant mechanism for this enhancing activity. Both transepidermal water loss (TEWL) and colorimetric evaluation showed limited irritation to skin by AO essential oils at the macroscopic level. Human skin fibroblasts were used to investigate the in vitro screening of skin toxicity. AO-1 slightly increased prostaglandin E(2) (PGE(2)) formation from skin fibroblasts. A striking result was observed with AO-2, which greatly inhibited the release of PGE(2). Moreover, both AO essential oils had no statistically significant effect on PGE(2) release by human lung epithelial cells. The results of this study indicate that skin disruption and inflammation do not necessary correspond to the enhancing efficiency of the enhancers tested.
Fang
Jia-You
JY
Graduate Institute of Natural Products, Chang Gung University, 259 Wen-Hwa 1st Road, Kwei-Shan, Tao-Yuan, Taiwan. fajy@mail.cgu.edu.tw
Leu
Yann-Lii
YL
Hwang
Tsong-Long
TL
Cheng
Hsiao-Chin
HC
Hung
Chi-Feng
CF
D032429:Alpinia / Q000737:chemistry*; D000818:Animals; D002478:Cells, Cultured; D004058:Diffusion; D005347:Fibroblasts / Q000187:drug effects / Q000502:physiology; D005638:Fruit / Q000737:chemistry; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D009822:Oils, Volatile / Q000302:isolation & purification / Q000493:pharmacokinetics* / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D020545:Respiratory Mucosa / Q000187:drug effects / Q000502:physiology; D012717:Sesquiterpenes / Q000302:isolation & purification / Q000493:pharmacokinetics* / Q000494:pharmacology; D012869:Skin Absorption / Q000187:drug effects / Q000502:physiology*; D012879:Skin Physiological Phenomena
D009822:Oils, Volatile; D012717:Sesquiterpenes